Arginine

Arginine

SCHEMBL285822

CSCC[C@H](N)C(=O)O.C[C@@H](O)[C@H](N)C(=O)O.N=C(N)NCCC[C@H](N)C(=O)O.N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FNTA P49354 12/20 0.35
FNTB P49356 12/20 0.35
PGGT1B P53609 12/20 0.35
CTSL P07711 3/20 0.33
CTSS P25774 3/20 0.33
CTSK P43235 3/20 0.33
CTSH P09668 1/20 0.33
APLNR P35414 1/20 0.33
NPY4R P50391 2/20 0.32
NPY1R P25929 1/20 0.32
NPY2R P49146 1/20 0.32
NPY5R Q15761 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL23362144 0.95 FNTA (0.37) FNTAFNTBPGGT1BCTSLCTSS
Arginine SCHEMBL8512347 0.95 FNTA (0.37) FNTAFNTBPGGT1BCTSLCTSS
Arginine SCHEMBL8510534 0.93 CTSL (0.31) FNTAFNTBPGGT1BCTSLCTSS
Arginine SCHEMBL27607779 0.87 APLNR (0.36) FNTAFNTBPGGT1BCTSLCTSS
Arginine SCHEMBL17113849 0.87 OTC (0.38) NPY4RNPY1RNPY2RNPY5R
Arginine SCHEMBL176372 0.87 OTC (0.38) NPY4RNPY1RNPY2RNPY5R
Arginine SCHEMBL13730532 0.87 OTC (0.38) NPY4RNPY1RNPY2RNPY5R
Arginine SCHEMBL17113847 0.87 OTC (0.38) NPY4RNPY1RNPY2RNPY5R
Arginine SCHEMBL21273831 0.87 OTC (0.38) NPY4RNPY1RNPY2RNPY5R
Arginine SCHEMBL23242196 0.87 OTC (0.38) NPY4RNPY1RNPY2RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120135931-A1 METHOD OF MODIFYING SERINE PROTEASE INHIBITORS NATURAL ENVIRONMENT RESEARCH COUNCIL (GB) 2012-05-31 US disclosed
EP-2427487-A2 METHOD OF MODIFYING SERINE PROTEASE INHIBITORS Natural Environment Research Council (GB) 2012-03-14 EP disclosed
WO-2010128285-A2 METHOD OF MODIFYING SERINE PROTEASE INHIBITORS NATURAL ENVIRONMENT RESEARCH COUNCIL (GB) 2010-11-11 WO disclosed